Business Context and Reporting Period
This Form 8-K Current Report is filed by Nukkleus Inc. (not T3 Defense Inc.) for the reporting period ending December 18, 2024. The filing details a material definitive agreement involving a private placement of equity securities and the termination of a prior standby equity purchase agreement.
Key Financial Metrics and Transaction Details
- Private Placement Proceeds: The Company agreed to sell 1,666,666 units for an aggregate purchase price of $10,000,000.
- Unit Pricing: Units were priced at $6.00 per unit, consisting of one share of common stock and one common stock purchase warrant (exercisable for 1.5 shares).
- Placement Fees: The Company paid a cash fee equal to 7.0% of gross proceeds to the placement agent, plus 4.0% on proceeds from warrant exercises.
- Outstanding Debt: A Convertible Promissory Note in the principal amount of $500,000 issued to YA II PN Ltd. remains outstanding and unaffected by recent terminations.
- Equity Grants: The Company issued 1,337,500 restricted shares of common stock to executive officers, directors, and consultants on December 16, 2024.
Material Changes and Agreements
- Securities Purchase Agreement: Entered on December 18, 2024, with closing on December 20, 2024. The Company must file a registration statement within 15 days and have it declared effective within 45 days (or 75 days if reviewed).
- Liquidated Damages: If the Company misses filing or effectiveness deadlines, it must pay the purchaser 5.0% of the aggregate purchase price as partial liquidated damages.
- Termination of SEPA: On December 19, 2024, the Company terminated the Standby Equity Purchase Agreement (SEPA) and Registration Rights Agreement with YA II PN Ltd., effective immediately, except for the $500,000 Convertible Note.
Outlook, Risks, and Management Commentary
- Registration Obligations: The Company is required to register the resale of shares and warrants issued in the private placement. Failure to meet strict deadlines triggers financial penalties.
- Compensation Structure: The restricted stock grants were issued to compensate long-serving executives and directors who previously received limited or no compensation.
- Regulatory Status: Securities were issued under Section 4(a)(2) and/or Rule 506 of Regulation D exemptions. The filing explicitly states it is not an offer to sell securities in the U.S. absent registration.
Investor Verification Checklist
- Verify the actual closing date of the $10 million private placement (stated as December 20, 2024).
- Confirm the filing status of the required registration statement for the resale of shares and warrants.
- Review the terms of the $500,000 Convertible Promissory Note to YA II PN Ltd. to understand conversion triggers and interest rates.
- Check the dilution impact of the 1,666,666 new units and the 1,337,500 restricted stock grants on existing shareholders.
- Monitor the Company's ability to meet the 45-day effectiveness deadline to avoid the 5% liquidated damages penalty.